ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #12,579Review JournalSubscription

Critical Reviews in Therapeutic Drug Carrier Systems

Abbreviation (ISO):CRIT. REV. THER. DRUG CARRIER SYST
•
Identifier (ISSN):0743-4863(Print)/2162-660X(Online)
•
Publisher:Begell House Inc.
Clarivate IF (2026)
2.5– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Critical Reviews in Therapeutic Drug Carrier Systems

WoS Q3
13572.4120182.920192.120204.8920213.120222.72023320242.520252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q2
0.469
#12,579

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
88

88 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate13.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessSubscription
18articles/year
0% Gold OA•0% Original Research

Aims & Scope

Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields. Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.

Topics Covered (Recognized by AI)
Medicine95.1%Biology73.2%Chemistry68.3%Materials science58.7%Organic chemistry57.6%Pharmacology57%Nanotechnology55.3%Drug delivery49%Psychology48.1%Psychiatry46.2%Drug44.7%Genetics44.1%Biochemistry43.2%Internal medicine36.3%Physics34.9%Engineering32.6%Bioinformatics22.4%Chemical engineering21.3%Immunology20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank205/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q4
Rank270/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year10
Total Citations0
2025
IF2.5
Articles / Year28
Total Citations37
2024
IF3
Articles / Year17
Total Citations68
2023
IF2.7
Articles / Year25
Total Citations112
2022
IF3.097
Articles / Year29
Total Citations246

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,579Scopus Q2SCImago Profile
Scopus Coverage:1984-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.469

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.22

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,924 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations188
3-Year Documents53
Citable Documents53

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate56.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ2
Medicine (miscellaneous)Q3
PharmacologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 13.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Critical Reviews in Therapeutic Drug Carrier Systems (abbr: CRIT. REV. THER. DRUG CARRIER SYST, ISSN: 0743-4863) is a peer-reviewed international scholarly journal in the field of Medicine, published by Begell House Inc. in United States since 1984. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.469 (Q2), an H-index of 88.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 18 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,924 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Subscription
Publisher
Begell House Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1984
Indexing & Databases
SCIEScopusPubMed
Editorial Address
BEGELL HOUSE INC, 50 CROSS HIGHWAY, REDDING, USA, CT, 06896

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: d30f6a60-1c98-4a3e-82af-f37dd31c70c9
Database Updated: 2026-10-01